AS Latvijas Juras medicinas centrs (RSE:LJM1R)
Latvia flag Latvia · Delayed Price · Currency is EUR
7.80
-0.05 (-0.64%)
Inactive · Last trade price on Mar 9, 2026

RSE:LJM1R Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
10.2910.199.859.79.36
Revenue Growth (YoY)
0.98%3.42%1.54%3.60%32.24%
Cost of Revenue
9.559.469.088.537.77
Gross Profit
0.730.720.771.171.6
Selling, General & Admin
0.760.690.670.710.58
Other Operating Expenses
-0.29-0.150.17-0.170.14
Operating Expenses
0.480.550.840.540.72
Operating Income
0.260.18-0.070.630.88
EBT Excluding Unusual Items
0.260.18-0.070.630.88
Asset Writedown
---0.55--
Pretax Income
0.260.18-0.620.630.88
Income Tax Expense
0.02-000
Earnings From Continuing Operations
0.240.18-0.620.630.88
Net Income
0.240.18-0.620.630.88
Net Income to Common
0.240.18-0.620.630.88
Net Income Growth
35.23%---28.92%221.78%
Shares Outstanding (Basic)
11111
Shares Outstanding (Diluted)
11111
EPS (Basic)
0.300.22-0.780.781.10
EPS (Diluted)
0.300.22-0.780.781.10
EPS Growth
35.23%---28.92%221.79%
Free Cash Flow
0.390.19-0.570.46-0.69
Free Cash Flow Per Share
0.490.24-0.710.58-0.86
Dividend Per Share
-0.100--0.200
Dividend Growth
----185.71%
Gross Margin
7.13%7.12%7.83%12.05%17.07%
Operating Margin
2.51%1.75%-0.74%6.46%9.41%
Profit Margin
2.34%1.75%-6.34%6.45%9.40%
Free Cash Flow Margin
3.78%1.86%-5.75%4.78%-7.39%
EBITDA
0.880.80.481.051.17
EBITDA Margin
8.55%7.85%4.86%10.87%12.47%
D&A For EBITDA
0.620.620.550.430.29
EBIT
0.260.18-0.070.630.88
EBIT Margin
2.51%1.75%-0.74%6.46%9.41%
Effective Tax Rate
6.69%--0.10%0.07%
Advertising Expenses
-0.030.020.010
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.